We hereby submit intimation regarding approval of ESOP Scheme 2026.

YH/SE/32/2026-27 August 10, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai -400001, India Symbol: YATHARTH Scrip Code: 543950 ISIN: INE0JO301016 ISIN: INE0JO301016 Sub: Outcome of Board Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 (“SEBI Listing Regulations, 2015”) Dear Sir/Madam, Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform you that the Board of Directors of Yatharth Hospital & Trauma Care Services Limited (“Company”), at its meeting held today, i.e., August 10, 2026, has, inter alia, considered and approved the following items: 1. Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended June 30, 2026. A copy of the said financial results, along with the Limited Review Report issued by M/s. M S K A & Associates LLP (formerly known as M/s. M S K A & Associates) bearing FRN: 105047W/W101187, statutory auditors of the Company is enclosed herewith as “Annexure-A”. 2. Declaration of the first interim dividend during the Financial Year 2026-27. In continuation to our Letter No. YH/SE/28/2026-27 dated August 04, 2026 and pursuant to Regulation 30 of SEBI LODR Regulations, we hereby inform you that the Board of Directors have approved & declared the first Interim Dividend of Rs. 0.50/- (Fifty Paisa) per equity share of face value of ₹ 10 each (being 5%) during the Financial Year 2026-27 amounting to Rs. 4,81,77,178.50/- (Rupees Four Crore Eighty One Lakh Seventy Seven Thousand One Hundred Seventy Eight and Fifty Paisa Only). 3. Record Date for Determining the entitlement of the members to the First Interim Dividend during the Financial Year 2026-27. Pursuant to the Regulation 42 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company has fixed the record date, i.e. Friday, August 14, 2026 for the purpose of the aforesaid interim dividend. 4. Approval of the “Yatharth Hospital & Trauma Care Services Employees Stock Option Scheme - 2026” for the Company and its Subsidiaries in terms of SEBI (Share Based Employee Benefits and Sweat Equity) regulations, 2021. The Board of Directors, at their meeting held today, based on the recommendation of the Nomination and Remuneration Committee, has inter alia considered, and approved the Introduction of ‘Yatharth Hospital & Trauma Care Services Employees Stock Option Scheme 2026’ (“ESOP 2026”) and related matters which will be subject to approval by the shareholders’. The details of the same as required pursuant to Regulation 30 of the Listing Regulations read with Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is annexed as “Annexure-B” to this letter. 5. Re-appointment of Cost Auditor for the financial year 2026-27. Re-appointment of M/s Subodh Kumar & Co., Cost Accountants (Firm registration number: 104250) as the Cost Auditor of the Company, for the Financial Year 2026-27. The detailed disclosure as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as “Annexure-C”. The above information will also be made available on website of the Company at https://www.yatharthhospitals.com/investors/financial-section/quaterly-results The Board Meeting commenced at 02:33 PM (IST) and concluded at 03:41 PM (IST). This is for your kind information and records. Thanking You Yours Faithfully, For Yatharth Hospital & Trauma Care Services Limited Ritesh Mishra Company Secretary & Compliance Officer M. No. A51166 Encl.: A/a MSKA & Associates LLP Magnum Global Park Unit No-2101-211 SA & 8, Floor 21 (Formerly known as MS KA & Associates) Sector-58, Arch View Drive Gurugram 122011, INDIA Chartered Accountants Independent Auditor's Review Report on Standalone unaudited financial results of Yatharth Hospital & Trauma Care Services Limited for the quarter pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To The Board of Directors of Yatharth Hospital & Trauma Care Services Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results of Yatharth Hospital & Trauma Care Services Limited (hereinafter referred to as 'the Company') for the quarter ended June 30, 2026 ('the Statement') attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange .Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations'). 2. This Statement, which is the responsibility of the Company's Management and has been approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting', prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder ('Ind AS 34') and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 I LLPIN: ACT-3789 Ahmedabad I Bengaluru I Chandigarh I Chennai I Coimbatore I Goa I Hyderabad I Kochi I Kolkata I Mumbai I Pune www.mska.in MSKA & Associates LLP (Formerly known as MS KA & Associates) Chartered Accountants 5. The Statement of the Company for the quarter ended June 30, 2025, was reviewed by another auditor whose report dated August 05, 2025, expressed an unmodified conclusion on that Statement. For MS KA & Associates LLP (formerly known as MS KA & Associates) Chartered Accountants ICAI Firm Registration No. 105047W /W101187 Sumit Verma Partner Membership No. : 509426 UDIN: 26509426BLPECH1033 Place: Gurugram Date: August 10, 2026 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 I LLPIN: ACT-3789 Ahmedabad I Bengaluru I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kechi I Kolkata I Mumbai I Pune www.mska.in Y ATHARTH HOSPITAL ft [Showing first 8,000 characters — download PDF for full document]